Growth Metrics

Collegium Pharmaceutical (COLL) Amortizatization of Intangibles (2017 - 2026)

Collegium Pharmaceutical has reported Amortizatization of Intangibles over the past 9 years, most recently at $55.5 million for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles changed 0.0% year-over-year to $55.5 million; the TTM value through Dec 2025 reached $221.9 million, up 34.23%, while the annual FY2025 figure was $221.9 million, 10841.42% up from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $55.5 million at Collegium Pharmaceutical, roughly flat from $55.5 million in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $55.5 million in Q1 2025 and troughed at $16.8 million in Q1 2021.
  • A 5-year average of $36.8 million and a median of $37.5 million in 2023 define the central range for Amortizatization of Intangibles.
  • Biggest five-year swings in Amortizatization of Intangibles: skyrocketed 151.74% in 2022 and later dropped 18.37% in 2023.
  • Year by year, Amortizatization of Intangibles stood at $16.8 million in 2021, then skyrocketed by 151.74% to $42.3 million in 2022, then decreased by 18.37% to $34.5 million in 2023, then skyrocketed by 60.72% to $55.5 million in 2024, then rose by 0.0% to $55.5 million in 2025.
  • Business Quant data shows Amortizatization of Intangibles for COLL at $55.5 million in Q4 2025, $55.5 million in Q3 2025, and $55.5 million in Q2 2025.